289 related articles for article (PubMed ID: 35597301)
1. Long non-coding RNA CYTOR modulates cancer progression through miR-136-5p/MAT2B axis in renal cell carcinoma.
Wang D; Zhu X; Siqin B; Ren C; Yi F
Toxicol Appl Pharmacol; 2022 Jul; 447():116067. PubMed ID: 35597301
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA Cytoskeleton Regulator RNA Suppresses Apoptosis in Hepatoma Cells by Modulating the miR-125a-5p/HS1-Associated Protein X-1 Axis to Induce Caspase-9 Inactivation.
Wu ZY; Wang Y; Hu H; Ai XN; Zhang Q; Qin YG
Gut Liver; 2023 Nov; 17(6):916-925. PubMed ID: 36700300
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA (lncRNA) CYTOR promotes hepatocellular carcinoma proliferation by targeting the microRNA-125a-5p/LASP1 axis.
Liu Y; Geng X
Bioengineered; 2022 Feb; 13(2):3666-3679. PubMed ID: 35081873
[TBL] [Abstract][Full Text] [Related]
4. LncRNA CYTOR affects the proliferation, cell cycle and apoptosis of hepatocellular carcinoma cells by regulating the miR-125b-5p/KIAA1522 axis.
Hu B; Yang XB; Yang X; Sang XT
Aging (Albany NY); 2020 Dec; 13(2):2626-2639. PubMed ID: 33318318
[TBL] [Abstract][Full Text] [Related]
5. LncRNA CYTOR promotes pancreatic cancer cell proliferation and migration by sponging miR-205-5p.
Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
Pancreatology; 2020 Sep; 20(6):1139-1148. PubMed ID: 32732173
[TBL] [Abstract][Full Text] [Related]
6. LncRNA RP11-436H11.5, functioning as a competitive endogenous RNA, upregulates BCL-W expression by sponging miR-335-5p and promotes proliferation and invasion in renal cell carcinoma.
Wang K; Jin W; Song Y; Fei X
Mol Cancer; 2017 Oct; 16(1):166. PubMed ID: 29070041
[TBL] [Abstract][Full Text] [Related]
7. Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.
Wu C; Zhang J
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185692
[TBL] [Abstract][Full Text] [Related]
8. The long noncoding RNA EMBP1 inhibits the tumor suppressor miR-9-5p and promotes renal cell carcinoma tumorigenesis.
Hong Y; Yuan Z; Huang R; Wu Z; Li Y
Nefrologia (Engl Ed); 2020; 40(4):429-439. PubMed ID: 32482375
[TBL] [Abstract][Full Text] [Related]
9. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.
Wang Z; Chang X; Zhu G; Gao X; Chang L
Cell Cycle; 2020 Aug; 19(16):2054-2062. PubMed ID: 32663095
[TBL] [Abstract][Full Text] [Related]
10. LncRNA CYTOR drives L-OHP resistance and facilitates the epithelial-mesenchymal transition of colon carcinoma cells via modulating miR-378a-5p/SERPINE1.
Yang J; Ma Q; Zhang M; Zhang W
Cell Cycle; 2021 Jul; 20(14):1415-1430. PubMed ID: 34224332
[TBL] [Abstract][Full Text] [Related]
11. lncRNA Gm15290 promotes cell proliferation and invasion in lung cancer through directly interacting with and suppressing the tumor suppressor
Dong Y; Huo X; Sun R; Liu Z; Huang M; Yang S
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30287504
[TBL] [Abstract][Full Text] [Related]
12. LncRNA CYTOR attenuates sepsis-induced myocardial injury via regulating miR-24/XIAP.
Chen T; Zhu C; Ye C
Cell Biochem Funct; 2020 Oct; 38(7):976-985. PubMed ID: 32181504
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA.
Wang W; Hu W; Wang Y; An Y; Song L; Shang P; Yue Z
Mol Cancer; 2020 Jan; 19(1):18. PubMed ID: 31996265
[TBL] [Abstract][Full Text] [Related]
14. lncRNA 00312 Attenuates Cell Proliferation and Invasion and Promotes Apoptosis in Renal Cell Carcinoma via miR-34a-5p/ASS1 Axis.
Zeng J; Li Y; Wang Y; Xie G; Feng Q; Yang Y; Feng J
Oxid Med Cell Longev; 2020; 2020():5737289. PubMed ID: 32308805
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA
Li J; Sun K; Zhang M; Luo Y; Zhang Y; Huang C; Hong J; Chen D; Liao W
Am J Cancer Res; 2023; 13(6):2714-2731. PubMed ID: 37424812
[TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNA DUXAP8 Enhances Renal Cell Carcinoma Progression via Downregulating miR-126.
Huang T; Wang X; Yang X; Ji J; Wang Q; Yue X; Dong Z
Med Sci Monit; 2018 Oct; 24():7340-7347. PubMed ID: 30317248
[TBL] [Abstract][Full Text] [Related]
17. CRNDE mediates the viability and epithelial-mesenchymal transition of renal cell carcinoma via miR-136-5p.
Zhang Y; Lan X; Wang Y; Liu C; Cui T
J Recept Signal Transduct Res; 2021 Jun; 41(3):234-244. PubMed ID: 32808846
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p/ACVR2B signaling.
Ye Y; Zhang F; Chen Q; Huang Z; Li M
Mol Carcinog; 2019 Feb; 58(2):279-292. PubMed ID: 30334578
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.
Sun Y; Jiang T; Jia Y; Zou J; Wang X; Gu W
Cell Cycle; 2019 Oct; 18(19):2509-2523. PubMed ID: 31397203
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA DLEU2 promotes the progression of esophageal cancer through miR-30e-5p/E2F7 axis.
Lu T; Wang R; Cai H; Cui Y
Biomed Pharmacother; 2020 Mar; 123():109650. PubMed ID: 31884338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]